Dr. Andrew Harbin

Dr. Andrew Harbin
Dr. Harbin practices all aspects of general urology and has a special interest in robotic urologic surgery, kidney cancer, prostate cancer, benign prostate disease, and kidney stones. He joined Chesapeake Urology in 2017 following two years with Frederick Urology Specialists, Frederick, MD. He completed a fellowship in Robotic Urologic Surgery at Temple University Hospital in Philadelphia in 2015. During his fellowship in Philadelphia, he focused on complex robotic surgery including kidney, prostate and bladder cancer, as well as robotic reconstructive surgery. He published several articles and gave presentations on the newest minimally invasive surgical techniques. While obtaining his medical education, Dr. Harbin worked on a number of research grants. He helped set up a student-doctor observation program, a suture clinic, fundraisers, and lectures for pre-clinical students interested in surgery. Dr. Harbin also took the opportunity to expand his medical experience overseas. During medical school, he studied for a month in India, while, as a resident, he took part in a Medical Mission trip to perform hydrocelectomies and hernia repairs in Haiti. Dr. Harbin received both the Researcher and Resident of the Year awards at Georgetown University Hospital in 2014. He is a peer reviewer for the Urologic Oncology Journal.
Medical School:

Tulane University School of Medicine

Residency:

Georgetown University

Fellowship:

Temple University

Locations

Chesapeake Urology Associates Westminster, MD

410 Malcolm Drive, Suite AWestminster, Maryland, 21157United States
410-876-1633 | Visit Website

All surgical treatments have inherent and associated side effects. Individual’s outcomes may depend on a number of factors, including but not limited to patient characteristics, disease characteristics and/or surgeon experience. The most common side effects are mild and transient and may include mild pain or difficulty when urinating, discomfort in the pelvis, blood in the urine, inability to empty the bladder or a frequent and/or urgent need to urinate, and bladder or urinary tract infection. Other risks include ejaculatory dysfunction and a low risk of injury to the urethra or rectum where the devices gain access to the body for treatment. Further, there may be other risks as in other urological surgery, such as anesthesia risk or the risk of infection, including the potential transmission of blood borne pathogens. For more information about potential side effects and risks associated with Aquablation therapy for Benign Prostatic Hyperplasia (BPH) treatment, speak with your urologist or surgeon. Prior to using our products, please review the Instructions for Use, Operator’s Manual or User Manual, as applicable, and any accompanying documentation for a complete listing of indications, contraindications, warnings, precautions and potential adverse events. No claim is made that the AquaBeam Robotic System will cure any medical condition, or entirely eliminate the diseased entity. Repeated treatment or alternative therapies may sometimes be required.

Rx Only